Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
The price of Taysha Gene Therapies Inc (NASDAQ: TSHA) closed at $1.25 in the last session, up 6.41% from day before closing price of $1.17. In other words, the price has increased by $6.41 from its previous closing price. On the day, 0.86 million shares were traded. TSHA stock price reached its highest trading level at $1.27 during the session, while it also had its lowest trading level at $1.14.
Ratios:
We take a closer look at TSHA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 5.41 and its Current Ratio is at 5.41. In the meantime, Its Debt-to-Equity ratio is 0.89 whereas as Long-Term Debt/Eq ratio is at 0.86.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BMO Capital Markets on June 27, 2024, initiated with a Outperform rating and assigned the stock a target price of $5.
On April 09, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $9.
Jefferies Downgraded its Buy to Hold on February 01, 2023, whereas the target price for the stock was revised from $14 to $1.50.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 27 ’24 when Manning Paul B bought 1,333,333 shares for $2.25 per share. The transaction valued at 2,999,999 led to the insider holds 1,333,333 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TSHA now has a Market Capitalization of 255227488 and an Enterprise Value of 179750032. For the stock, the TTM Price-to-Sale (P/S) ratio is 30.64 while its Price-to-Book (P/B) ratio in mrq is 3.57. Its current Enterprise Value per Revenue stands at 21.571 whereas that against EBITDA is -2.105.
Stock Price History:
The Beta on a monthly basis for TSHA is 1.01, which has changed by -0.5319549 over the last 52 weeks, in comparison to a change of 0.059571505 over the same period for the S&P500. Over the past 52 weeks, TSHA has reached a high of $4.32, while it has fallen to a 52-week low of $1.05. The 50-Day Moving Average of the stock is -22.06%, while the 200-Day Moving Average is calculated to be -36.32%.
Shares Statistics:
According to the various share statistics, TSHA traded on average about 2.16M shares per day over the past 3-months and 3201020 shares per day over the past 10 days. A total of 204.94M shares are outstanding, with a floating share count of 165.01M. Insiders hold about 19.51% of the company’s shares, while institutions hold 77.26% stake in the company. Shares short for TSHA as of 1743379200 were 21631407 with a Short Ratio of 10.02, compared to 1740700800 on 25530638. Therefore, it implies a Short% of Shares Outstanding of 21631407 and a Short% of Float of 13.919999999999998.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
